OPPM
Opus Point Partners Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $261K | Hold |
1,123
| – | – | 0.47% | 45 |
|
2019
Q2 | $263K | Buy |
+1,123
| New | +$263K | 0.39% | 55 |
|
2019
Q1 | – | Sell |
-1,062
| Closed | -$320K | – | 75 |
|
2018
Q4 | $320K | Buy |
1,062
+30
| +3% | +$9.04K | 0.7% | 22 |
|
2018
Q3 | $365K | Sell |
1,032
-2,500
| -71% | -$884K | 0.87% | 38 |
|
2018
Q2 | $1.03M | Buy |
3,532
+15
| +0.4% | +$4.35K | 2.22% | 18 |
|
2018
Q1 | $963K | Sell |
3,517
-2,276
| -39% | -$623K | 1.89% | 16 |
|
2017
Q4 | $1.85M | Sell |
5,793
-894
| -13% | -$285K | 1.6% | 18 |
|
2017
Q3 | $2.09M | Buy |
6,687
+910
| +16% | +$285K | 1.88% | 22 |
|
2017
Q2 | $1.57M | Sell |
5,777
-5,627
| -49% | -$1.53M | 1.44% | 23 |
|
2017
Q1 | $3.12M | Buy |
11,404
+532
| +5% | +$145K | 2.31% | 21 |
|
2016
Q4 | $3.08M | Buy |
10,872
+168
| +2% | +$47.6K | 2.46% | 15 |
|
2016
Q3 | $3.35M | Buy |
10,704
+1,662
| +18% | +$520K | 1.88% | 10 |
|
2016
Q2 | $2.19M | Sell |
9,042
-2,083
| -19% | -$504K | 2.11% | 22 |
|
2016
Q1 | $2.9M | Buy |
11,125
+643
| +6% | +$167K | 2.24% | 20 |
|
2015
Q4 | $3.21M | Sell |
10,482
-6,985
| -40% | -$2.14M | 2.12% | 21 |
|
2015
Q3 | $5.1M | Buy |
17,467
+6,213
| +55% | +$1.81M | 2.81% | 6 |
|
2015
Q2 | $4.55M | Buy |
11,254
+1,923
| +21% | +$777K | 3.6% | 9 |
|
2015
Q1 | $3.94M | Sell |
9,331
-155
| -2% | -$65.4K | 3.3% | 8 |
|
2014
Q4 | $3.22M | Buy |
+9,486
| New | +$3.22M | 3.19% | 12 |
|